REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Racz-Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Racz-Pharma Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Racz-Pharma Kft. is based in Hungary, with the head office in Nyiregyhaza. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on July 01, 2018. 7 (2023) employees currently work for Racz-Pharma Kft.. The company’s latest financial report indicates a net sales revenue drop of 0.65% in 2022. There was a total negative growth of 0.26% in Racz-Pharma Kft.’s total assets over the same period. In 2022, Racz-Pharma Kft.’s net profit margin decreased by 3.43%.

Headquarters
Toldi utca 51.
Nyiregyhaza; Szabolcs-Szatmar-Bereg; Postal Code: 4400

Contact Details: Purchase the Racz-Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Racz-Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Racz-Pharma Kft. report to view the information.
Registered Capital:
Purchase the Racz-Pharma Kft. report to view the information.
Incorporation Date:
July 01, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Racz-Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-0.65%▼
Total operating revenue
-0.5%▼
Operating profit (EBIT)
-91.18%▼
EBITDA
-77.59%▼
Net Profit (Loss) for the Period
-99.83%▼
Total assets
-0.26%▼
Total equity
0.06%▲
Operating Profit Margin (ROS)
-3.47%▼
Net Profit Margin
-3.43%▼
Return on Equity (ROE)
-33.18%▼
Quick Ratio
-0.17%▼
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo